Company / Revenue per Share
GYRE THERAPEUTICS, INC. Revenue per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$1.35
FY2025
5-year range
$0.33 / $1.61
FY2021-FY2025
Trend
-2.2%
vs FY2024
Sector context
#100 of 154
Health Care
What the data says
At $1.35, GYRE THERAPEUTICS, INC.'s revenue per share ranks #100 of 154 in the Health Care sector. Revenue per Share has fluctuated over the past 8 years, ranging from $0.17 in FY2018 to $1.74 in FY2020.
Based on SEC 10-K filings.
1.35 in FY2025 with a 5-year CAGR of -4.9%.
Declined from $1.61 to $1.35 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -0.0%
- 5-Year CAGR
- -4.9%
- 10-Year CAGR
- -
Sector benchmark
#100 of 154 in Health CareTop 65% of 154This company $1.35 Sector average $10.35
▼
-87.0% below sector average
Key checks
Key Insights
- In FY2025, revenue per share decreased 2.2% year-over-year.
- Ranks #100 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2020.
- Lowest revenue per share in the period was in FY2018.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.35 | -2.2% |
| FY2024 | $1.38 | -14.2% |
| FY2023 | $1.61 | +19.0% |
| FY2022 | $1.35 | +307.0% |
| FY2021 | $0.33 | -80.9% |
| FY2020 | $1.74 | - |
| FY2019 | - | - |
| FY2018 | $0.17 | -43.7% |
| FY2017 | $0.30 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026